ATHX Athersys Inc

Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2016 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 9, 2016, and host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

Date	August 9, 2016
Time	4:30 p.m. (Eastern Time)
Telephone access: US and Canada	(800) 273-1254
Telephone access: International	(973) 638-3440
Access code	45914024
Live webcast	www.athersys.com under Investors section

A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on August 23, 2016 at the aforementioned URL, or by dialing (800) 585-8367 or (855) 859-2056 in the U.S. and Canada, or from abroad (404) 537-3406, and entering access code 45914024.

About Athersys

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More information is available at www.athersys.com.

Contact:
William (B.J.) Lehmann, J.D.                                     
President and Chief Operating Officer                                  
Tel: (216) 431-9900                            
bjlehmann@athersys.com